Kalaris Therapeutics (KLRS) Debt to Equity (2019 - 2020)
Kalaris Therapeutics (KLRS) has 2 years of Debt to Equity data on record, last reported at $0.0 in Q3 2020.
- For Q3 2020, Debt to Equity changed N/A year-over-year to $0.0; the TTM value through Sep 2020 reached $0.0, changed N/A, while the annual FY2019 figure was -$0.0, N/A changed from the prior year.
- Debt to Equity reached $0.0 in Q3 2020 per KLRS's latest filing, up from -$0.01 in the prior quarter.
- Across five years, Debt to Equity topped out at $0.0 in Q3 2020 and bottomed at -$0.01 in Q2 2020.